Budgeted Quotient-Residual Guidance (QRG) is an inference-time correction that enables quotient-based lead‑optimization objectives—such as distances, contacts, and anchored substructures—to be actively used with frozen pocket‑conditioned molecular diffusion models without retraining. QRG lifts quotient covectors to metric‑horizontal ambient directions and delivers them through a trust budget set by the sampler’s step norm, providing a closed‑form sampler‑budget update and a product‑budget split for section and residual controls. Experiments on frozen TargetDiff backbones show that QRG improves ligand‑generation quality on fragment growing, scaffold hopping, and linker design while preserving novelty and diversity.
arXiv:2607. 02834v1 Announce Type: new Abstract: Molecular optimization often starts from a pretrained generative model that captures a broad prior over valid molecular structures.
arXiv:2608. 13800v1 Announce Type: new Abstract: Transition path sampling (TPS) aims to efficiently generate rare molecular transition trajectories between metastable states and is essential for understanding biomolecular mechanisms.
arXiv:2609.00189v1 Announce Type: new Abstract: Goal-directed optimization is essential for steering molecular generators to propose candidates with desired properties. However, it is often implement...
arXiv:2607. 26391v1 Announce Type: new Abstract: Oracle-limited molecular optimization gives reward only after a complete molecule is generated, while each rollout requires many local next-token decisions.
VGAS: Variance-Reduced Guidance and Adaptive Selection for Training-Free Reward Alignment in Discrete Diffusion proposes a new inference-time framework that improves steering of frozen masked discrete diffusion models. By reducing the variance of guidance estimates, applying reward tilting to clean-token logits, and adapting the selection temperature at each step, VGAS addresses three default choices in existing pipelines. Experiments on regulatory DNA, protein, and small-molecule benchmarks show that VGAS achieves the best training-free reward performance and matches or surpasses reward-fine-tuned generators.
arXiv:2606. 00555v1 Announce Type: new Abstract: Structure-based drug design increasingly employs LLM agents to iteratively refine ligands against a target pocket, yet a viable ligand must satisfy two often-conflicting objectives -- binding affinity and druggability -- which single optimization steps rarely improve together.
arXiv:2606. 23856v1 Announce Type: new Abstract: Generative molecular models for drug design are a promising direction with much active research.
The paper introduces MCTH (Monte Carlo Tree Hallucination), an inference-only framework that performs all‑atom biomolecular sequence‑structure co‑design by treating pretrained folding and inverse‑folding models as black‑box operators. MCTH uses Monte Carlo Tree Search to allocate a fixed inference budget across competing design trajectories, incorporating model confidence, uncertainty, and cross‑expert consensus. Experiments across protein‑RNA, protein‑DNA, protein‑protein, and protein‑ligand design show that adaptive search outperforms simpler sampling strategies, and evaluations with AlphaFold3 and Chai‑1 demonstrate transferability beyond the search‑time oracle.
arXiv:2606. 08375v1 Announce Type: new Abstract: All-atom generative modeling of 3D biomolecular complexes has emerged as the dominant paradigm for predicting the structure of proteins and protein-ligand systems.
PocketVE is a protein-pocket-conditioned variance‑exploding diffusion framework that integrates stable 3D coordinate denoising, classifier‑free property guidance, and adaptive protein perturbation. It improves 3D validity from 58.6% to 80.6% and reduces strain energy from 457.4 to 127.9 on CrossDocked2020 while maintaining competitive docking and property scores. The study shows moderate guidance balances target objectives with geometric quality, and diagnostics confirm enhanced pocket compatibility.
Oracle-limited molecular optimization gives reward only after a complete molecule is generated, while each rollout requires many local next-token decisions. This delayed-feedback interface makes molecular policy optimization myopic: an optimizer can learn that a molecule was good without knowing which intermediate actions made it good.
arXiv:2608.31009v1 Announce Type: new Abstract: Structure-based drug design (SBDD) requires ligands that satisfy both 3D target affinity and 1D chemical validity. Existing controllable generation met...